BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 20679471)

  • 1. Impaired cardiac sympathetic innervation and myocardial perfusion are related to lethal arrhythmia: quantification of cardiac tracers in patients with ICDs.
    Nishisato K; Hashimoto A; Nakata T; Doi T; Yamamoto H; Nagahara D; Shimoshige S; Yuda S; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2010 Aug; 51(8):1241-9. PubMed ID: 20679471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.
    Boogers MJ; Borleffs CJ; Henneman MM; van Bommel RJ; van Ramshorst J; Boersma E; Dibbets-Schneider P; Stokkel MP; van der Wall EE; Schalij MJ; Bax JJ
    J Am Coll Cardiol; 2010 Jun; 55(24):2769-77. PubMed ID: 20538172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.
    Wakabayashi T; Nakata T; Hashimoto A; Yuda S; Tsuchihashi K; Travin MI; Shimamoto K
    J Nucl Med; 2001 Dec; 42(12):1757-67. PubMed ID: 11752070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pooled analysis of multicenter cohort studies of (123)I-mIBG imaging of sympathetic innervation for assessment of long-term prognosis in heart failure.
    Nakata T; Nakajima K; Yamashina S; Yamada T; Momose M; Kasama S; Matsui T; Matsuo S; Travin MI; Jacobson AF
    JACC Cardiovasc Imaging; 2013 Jul; 6(7):772-84. PubMed ID: 23845574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting the need for an implantable cardioverter defibrillator using cardiac metaiodobenzylguanidine activity together with plasma natriuretic peptide concentration or left ventricular function.
    Nagahara D; Nakata T; Hashimoto A; Wakabayashi T; Kyuma M; Noda R; Shimoshige S; Uno K; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2008 Feb; 49(2):225-33. PubMed ID: 18199625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic prognostic implications of left ventricular mechanical dyssynchrony and impaired cardiac sympathetic nerve activity in heart failure patients with reduced left ventricular ejection fraction.
    Doi T; Nakata T; Yuda S; Hashimoto A
    Eur Heart J Cardiovasc Imaging; 2018 Jan; 19(1):74-83. PubMed ID: 28158459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval variability in type 2 diabetic patients with cardiac sympathetic dysinnervation assessed by 123I-metaiodobenzylguanidine scintigraphy.
    Sacre JW; Franjic B; Coombes JS; Marwick TH; Baumert M
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):305-13. PubMed ID: 23210722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiac sympathetic nervous function with left ventricular function and perfusion in cardiomyopathies by (123)I-MIBG SPECT and (99m)Tc-tetrofosmin electrocardiographically gated SPECT.
    Zhao C; Shuke N; Yamamoto W; Okizaki A; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
    J Nucl Med; 2001 Jul; 42(7):1017-24. PubMed ID: 11438621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing hearts.
    Nakata T; Miyamoto K; Doi A; Sasao H; Wakabayashi T; Kobayashi H; Tsuchihashi K; Shimamoto K
    J Nucl Cardiol; 1998; 5(6):579-90. PubMed ID: 9869480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.
    Marshall A; Cheetham A; George RS; Mason M; Kelion AD
    Heart; 2012 Sep; 98(18):1359-65. PubMed ID: 22904144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac sympathetic innervation assessed with (123)I-MIBG retains prognostic utility in diabetic patients with severe left ventricular dysfunction evaluated for primary prevention implantable cardioverter-defibrillator.
    García-González P; Fabregat-Andrés Ó; Cozar-Santiago P; Sánchez-Jurado R; Estornell-Erill J; Valle-Muñoz A; Quesada-Dorador A; Payá-Serrano R; Ferrer-Rebolleda J; Ridocci-Soriano F
    Rev Esp Med Nucl Imagen Mol; 2016; 35(2):74-80. PubMed ID: 26514320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of myocardial adrenergic innervation with a solid-state dedicated cardiac cadmium-zinc-telluride camera: first clinical experience.
    Gimelli A; Liga R; Giorgetti A; Genovesi D; Marzullo P
    Eur Heart J Cardiovasc Imaging; 2014 May; 15(5):575-85. PubMed ID: 24351314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anger recall mental stress decreases
    Avendaño R; Hashemi-Zonouz T; Sandoval V; Liu C; Burg M; Sinusas AJ; Lampert R; Liu YH
    J Nucl Cardiol; 2022 Apr; 29(2):798-809. PubMed ID: 33034036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 123 I-mIBG scintigraphy to predict inducibility of ventricular arrhythmias on cardiac electrophysiology testing: a prospective multicenter pilot study.
    Bax JJ; Kraft O; Buxton AE; Fjeld JG; Parízek P; Agostini D; Knuuti J; Flotats A; Arrighi J; Muxi A; Alibelli MJ; Banerjee G; Jacobson AF
    Circ Cardiovasc Imaging; 2008 Sep; 1(2):131-40. PubMed ID: 19808530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure.
    Kyuma M; Nakata T; Hashimoto A; Nagao K; Sasao H; Takahashi T; Tsuchihashi K; Shimamoto K
    J Nucl Med; 2004 Feb; 45(2):155-63. PubMed ID: 14960630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of exercise rehabilitation on myocardial perfusion and sympathetic heart innervation in ischaemic heart disease.
    Estorch M; Flotats A; Serra-Grima R; Mari C; Prat T; Martín JC; Bernà L; Catafau AM; Tembl A; Carrió I
    Eur J Nucl Med; 2000 Mar; 27(3):333-9. PubMed ID: 10774887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcome prediction by SPECT myocardial perfusion imaging after CT attenuation correction.
    Pazhenkottil AP; Ghadri JR; Nkoulou RN; Wolfrum M; Buechel RR; Küest SM; Husmann L; Herzog BA; Gaemperli O; Kaufmann PA
    J Nucl Med; 2011 Feb; 52(2):196-200. PubMed ID: 21270455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concordance between rest MIBG and exercise tetrofosmin defects: possible use of rest MIBG imaging as a marker of reversible ischaemia.
    Estorch M; Narula J; Flotats A; Marí C; Tembl A; Martín JC; del Valle Camacho M; Catafau AM; Serra-Grima R; Carrió I
    Eur J Nucl Med; 2001 May; 28(5):614-9. PubMed ID: 11383867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.
    Shah AM; Bourgoun M; Narula J; Jacobson AF; Solomon SD
    JACC Cardiovasc Imaging; 2012 Nov; 5(11):1139-46. PubMed ID: 23153914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification of patients with prior myocardial infarction and advanced left ventricular dysfunction by gated myocardial perfusion SPECT imaging.
    Morishima I; Sone T; Tsuboi H; Mukawa H; Uesugi M; Morikawa S; Takagi K; Niwa T; Morita Y; Murakami R; Numaguchi Y; Murohara T; Okumura K
    J Nucl Cardiol; 2008; 15(5):631-7. PubMed ID: 18761265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.